Clik here to view.
Healthcare+ Expo Taiwan 2019 Exhibitor Profiles
TAIPEI, Taiwan Healthcare+ Expo Taiwan runs December 5 – 8, 2019 at the at the Taipei Nangang Exhibition Center in Taipei, Taiwan. Business Wire is an official media partner for Healthcare+ Expo...
View ArticleClik here to view.
Nanomix Receives CE Mark for Diagnostic Panel That Aids in Rapid...
EMERYVILLE, Calif. Nanomix announced today that the company has received CE Mark for its S1 Assay for the rapid, simultaneous detection and quantification of lactate (LAC), procalcitonin (PCT), and...
View ArticleClik here to view.
Macrogen Research Outcome from ‘GenomeAsia 100K’ Covered in Nature
SEOUL, South Korea The precision medicine and biotechnology company Macrogen (Chairman Jung-Sun Seo, www.macrogen.com) (KOSDAQ: 038290) announced on Dec 5 that the result of its Asian genome...
View ArticleClik here to view.
Macrogen通过GenomeAsia 100K国际联盟获得的研究成果作为《自然》杂志正刊封面论文刊载
韩国首尔 (美国商业资讯)–精密医学生命工程企业Macrogen(会长徐正善 www.macrogen.com)(KOSDAQ: 038290)于5日发布消息称，其通过国际联盟“GenomeAsia 100K倡议（GenomeAsia 100K Initiative）”获得的亚洲人基因组分析研究成果已作为封面论文，刊载于最新一期的《自然（Nature）》杂志上。（论文名称：The...
View ArticleClik here to view.
マクロジェン、ゲノムアジア 100K 国際コンソーシアムの研究成果がネイチャー誌の巻頭論文として掲載
韓国ソウル （ビジネスワイヤ） – 精密医療・バイオテクノロジー企業であるマクロジェン（会長：ソ・ジョンソン, www.macrogen.com)(KOSDAQ: 038290)は国際コンソーシアムである「ゲノムアジア 100K イニシアチブ（GenomeAsia 100K...
View ArticleClik here to view.
LYNPARZA® (olaparib) Approved in China as a First-Line Maintenance Therapy in...
KENILWORTH, N.J. AstraZeneca and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the companies have received marketing authorization from China’s National...
View ArticleClik here to view.
Alpha Holdings Comments on OncoSec’s Inability to Defend China Grand Takeover
SEONGNAM, South Korea Alpha Holdings, Inc. (KOSDAQ: 117670) (“Alpha”), the largest stockholder of OncoSec Medical Incorporated (NASDAQ: ONCS) (“OncoSec”), with an approximate 15.1% ownership stake,...
View ArticleClik here to view.
2019年台湾医疗科技展展商简介
台湾台北 (美国商业资讯)–台湾医疗科技展(Healthcare+ Expo Taiwan)将于2019年12月5日至8日在台湾台北市的南港展览馆举行。 美国商业资讯是台湾医疗科技展的官方媒体合作伙伴。以下列出部分参展商资料，展商新闻和公告可在http://www.tradeshownews.com/events/Healthcare-Expo-Taiwan-2019/查询。 参展单位：...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Announces the Launch of Deferasirox Film-Coated...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the...
View ArticleClik here to view.
Takeda to Present Results from the Phase 3 TOURMALINE-AL1 Trial of NINLARO in...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that results of the TOURMALINE-AL1 trial will be presented during an oral session at the...
View ArticleClik here to view.
仁川市、松島グローバルバイオクラスターを造成してバイオの中心地を目指す
韓国仁川 （ビジネスワイヤ） — 仁川広域市は仁川経済自由区域内に松島グローバルバイオクラスターを造成する。 本プレスリリースではマルチメディアを使用しています。リリースの全文はこちらをご覧ください。：https://www.businesswire.com/news/home/20191209005026/ja/...
View ArticleClik here to view.
Incheon City Envisions Biotech Mecca by Developing Songdo Global Biotech Cluster
INCHEON, South Korea The Incheon Metropolitan City government announced an ambitious plan for developing the Songdo Global Biotech Cluster in the Incheon Free Economic Zone. This press release...
View ArticleClik here to view.
Takeda Demonstrates Its Long-Standing Commitment to Advancing Treatments for...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) (“Takeda”), today presented nine hematology poster presentations at the 61st American Society of Hematology (ASH) Annual...
View ArticleClik here to view.
Seattle Genetics and Takeda Announce Additional Analyses of ADCETRIS®...
BOTHELL, Wash. & CAMBRIDGE, Mass. & OSAKA, Japan Seattle Genetics, Inc. (Nasdaq:SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced additional analyses of...
View ArticleClik here to view.
Evaluate Ltd. appoints Martyn Hindley as Chief Financial Officer
LONDON & BOSTON & TOKYO Evaluate Ltd., the leading provider of commercial data to the life sciences industry, is pleased to announce the appointment of Martyn Hindley as Chief Financial...
View ArticleClik here to view.
Maruho和Solasia签署SP-04(PledOx®)代理许可及资本联盟协议
日本东京 (美国商业资讯)–苏爱康制药有限公司（东京证券交易所代码：4597，总部：日本东京，总裁兼首席执行官：荒井好裕，以下简称“苏爱康”）和Maruho有限责任公司（总部：日本大阪，总裁兼首席执行官：Koichi Takagi,...
View ArticleClik here to view.
ソレイジア・ファーマ: 開発品SP-04(効能・効果：がん化学療法に伴う末梢神経障害) 日本における独占的販売ライセンス契約締結および資本提携のお知らせ
東京 （ビジネスワイヤ） — マルホ株式会社（以下「マルホ」）とソレイジア・ファーマ株式会社（以下「ソレイジア」）は、ソレイジアが開発している開発品SP-04...
View ArticleClik here to view.
Solasia Announces License and Capital Alliance for SP-04 (PledOx®) with Maruho
TOKYO Solasia Pharma K.K. (TSE: 4597, Headquarters: Tokyo, Japan, President & CEO: Yoshihiro Arai, hereinafter “Solasia”) announced today that it has entered into an exclusive license agreement...
View ArticleClik here to view.
PolarityTE Builds Patent Portfolio with New International Patent Grants
SALT LAKE CITY PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, announced today that the company has recently...
View ArticleClik here to view.
武田薬品がアミロイドーシス患者でニンラーロを検討する第3相TOURMALINE-AL1試験の結果を発表へ
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） —...
View Article